Abstract: Human umbilical cord stroma-derived mesenchymal stem cells (hUCS-MSCs) are considered as a remarkable and promising stem cell source to be potentially used in cellular therapies. While no graft rejection has been reported in the recipient organism even in xeno-transplantation studies, attenuate tumor cell growth and gene transfers have been experimentally shown. In this study, we have demonstrated a reliable, reproducible and efficient cryopreservation method of hUCS-MSCs resulting in one of the highest cell survival rates reported so far. Conventional, computer-controlled multistep slow freezing (MSSF), and vitrification methods were comparatively tested using cell permeable [dimethylsulfoxide (DMSO), ethylene glycol] and impermeable [trehalose, sucrose, hydroxyethyl starch (HES), human serum albumin] cryoprotectant agents (CPAs). After determining the ice nucleation point for each solution, latent heat evolution was suppressed during freezing, followed by a cooling process to -40°C at 1°C/min or 0.3°C/min. The efficiency of the cryopreservation techniques used was determined by cell viability and proliferation assays, the expression of cell surface markers, cytoskeletal proteins and chromosome alignments. The cell survival rate was found to be highest (87±5%) by MSSF with sucrose (0.1 M) +DMSO (10%) at 1°C/min freezing rate. In this group, no significant difference was noted before and after the cryopreservation in cell morphology, cytokeratin, vimentin, and -smooth muscle actin profiles and the expressions of CD105, CD90, CD73, CD29 and HLA-DR. Second highest cell survival ratio (85±6%) was obtained in DMSO (10%) alone at 1°C/min freezing rate. Interestingly, poor (18±15%) cell survival rates were obtained after vitrification. Cumulatively, results indicated that MSSF favors the other freezing protocols with an addition of sucrose or DMSO alone depending on the freezing rate used.
INTRODUCTION
Over the last few years, human umbilical cord stromaderived stem cells (hUCS-MSCs) have been extensively investigated to understand their stem cell nature [1] [2] [3] . hUCS-MSCs are spindle to polyhedral-shaped myofibroblasts having the potential for multilineage differentiation into mesenchymal cells such as osteoblasts, adipocytes, chondrocytes and myoblasts under specific culture conditions, thus they are considered remarkable and promising stem cell source in cellular therapies [4] [5] [6] [7] . In addition to the mesenchymal lineages, they were also successfully differenttiated into functional neuron-like cells [8, 9] . Furthermore, no immune response or graft rejection has been reported in the recipient organism, even in the xenotransplantation studies [10] , attenuate tumor cell growth and gene transfers have been experimentally shown [11] . Human umbilical cord, a discarded tissue after birth, therefore stands as a valuable source of hUCS-MSCs that are easy to obtain and not associated with ethical debate. As fresh cells could only be isolated just after birth, isolated and propagated hUCS-MSCs should be cryo-preserved, preferably in GMP conditions until their use in both autologous and allogeneic therapies, when needed. Therefore, the cryopreservation protocol should allow a high survival rate and a long-term storage of hUCS-MSCs without any loss in their cellular characteristics.
Cryopreservation is a procedure, by which cells are suspended in a solution of salts and usually one or more lowmolecular-weight organic compounds, cooled to very low subzero temperatures (usually -196°C in liquid nitrogen), stored for extended period of time, then warmed and recovered to resume their normal function. This procedure is now applied regularly to oocytes and embryos of many mammalian species. Again, it would be wise to highlight the importance of embryo and oocyte cryopreservation in the current practice of human and animal medicine, agriculture, and biomedical research. Every year, hundreds of thousands of domestic animals are produced from frozen embryos and innumerable laboratory animals are produced in research laboratories from cryopreserved embryos [12] . In the case of humans, embryo cryopreservation has become an integral part of assisted reproductive technologies. For example, from 2005 to 2009 in the United States more than 37,000 pregnancies were produced by transfer of cryopreserved human embryos [13] . On the other hand, somatic human cells have been cryopreserved for more than 60 years when first efforts focused on human red blood cells, lymphocytes and immortal cell lines such as HeLa cells. More recently, human fibroblasts, keratinocytes and many others have been cryopreserved for prospective therapeutic uses. CD34
+ cord blood-derived stem cells may account as the most reputable human somatic cells ever cryopreserved worldwide in thousands of cell banks. Today, more than 400,000 cord blood units stored for unrelated use [14] . Concomitantly, many other human cells bearing varying degrees of stem cell character are preserved for both autologous and/or allogeneic therapeutic purposes. Therefore, feasible cell banking with little or no cell toxicity that would provide a high survival rate became a universal challenge among laboratories, clinics and cell banks.
With the introduction of cell-and tissue-based therapies, reliable cryopreservation and biobanking have become progressively important [15] since a variety of preclinical and clinical studies already showed the promising therapeutic value of various stem and progenitor cell transplantation protocols [16] . While cryopreservation of hematopoietic stem cells for clinical applications is routinely performed [17] , cryopreservation protocols for other emerging cells such as mesenchymal stem cells (MSCs) are under development and their practical effectiveness is still need to be demonstrated [4] . Formulating a cryopreservation protocol for the hUCS-MSCs is required because these cells cannot survive for longer periods under in vitro culture conditions [6] . The greatest challenge during cellular cryopreservation is the lethality of the cooling and thawing processes.
Optimization of cryopreservation protocols to maintain the quality of stem cells is a critical task for their banking. Cooling rate is known to have the most significant influence on cell survival [18] . Controlled-rate freezing before longterm storage maximizes viability for a wide variety of cells [19] . Ice nucleation represents the onset of a change of state from liquid to crystalline, at the time when latent heat of fusion occurs and causes an increase in temperature. Controlling nucleation and the temperature compensation provided during controlled-rate freezing for inhibiting the release of the latent heat of fusion result in improved post-freeze cell viability [20] . In addition to reducing the ice crystal formation, slow freezing has also been developed to eliminate the toxic and osmotic damage to cells through exposure to low concentration of cryoprotective agent (CPA) while slowly decreasing the temperature. Vitrification, on the other hand, as an alternative method is a rapid cooling with the aid of high concentration of CPA(s) [21] .
CPAs, as the indispensible additives during cooling process, can be classified in various ways, such as either low-MW or high-MW additives. A more traditional grouping of CPAs [22] depends upon the rate of penetration into the cell (permeable CPAs; P-CPAs); those that penetrate quickly, usually within 30 minutes, include methanol, ethanol, ethylene glycol (EG), propylene glycol (PG), dimethylformamide, methylacetamide, and dimethyl sulfoxide (DMSO); glycerol which penetrates more slowly. The permeability of some of these solutes (e.g., glycerol) depends strikingly on temperature and cell type, and some penetrating CPAs might be regarded as low-permeable compounds under some circumstances. Mono-, oligo-, and polysaccharides, mannitol, sorbitol, dextran, hydroxyethyl starch (HES), methyl cellulose, albumin, gelatin, water-soluble synthetic polymers like polyvinylpyrrolidone (PVP), polyethylene glycol (PEG), polyethylene oxide (PEO), or polyvinyl alcohol which are all nonpenetrating compounds (impermeable CPAs; IP-CPAs) that cause extracellular cryoprotection when present at concentrations of 10-40%. Moreover, some CPAs penetrate only in the cell wall (CW) of plants, bacteria, fungi, algae, and some archaea and not the cytoplasmic membrane (CM) of eukaryotes. Thus, three categories of CPAs might be distinguished [23] : (1) CPAs penetrating both CW and CM (e.g. DMSO, glycerol); (2) CPAs penetrating CW but not CM (mono-and disaccharides, amino acids, polymers with a low MW, e.g., PEG-1000); and (3) CPAs not penetrating even CW (polymers with a higher MW-proteins, polysaccharides, PEO, PEG-6000, dextran, HES, and PVP). Table 1 summarizes the most common CPAs used as an additive in cryo solutions for stem cell cryopreservations.
Human UC-MSCs were previously cryopreserved by an empiric slow freezing method (conventional freezing) using 7-10% DMSO [6, 9, 24] or glycerol [9] as cell permeable CPAs (P-CPAs). After rapid thawing at 37 °C, viability rates of cells were found over 50% [25] . Since most cell membranes are permeable to water and CPAs, a coupled flow of both occurs during freezing. The dynamics of this coupled flow dictate cell volume and intracellular concentrations during cryopreservation processing [26] . IP-CPAs such as sugars are often added to dilution media to prevent excessive osmotic swelling during post-thaw CPA removal [27] .
The purpose of this study was to test different combinations of P-CPAs and IP-CPAs at a given concentration using different cooling rates, which can be precisely aligned by a high-end programmable slow-rate freezer to obtain a better vitality of hUCS-MSCs without or little formation of ice crystal injury to cell membrane which would allow to maintain their stemness and differentiation characteristics.
MATERIALS AND METHODS

Isolation and Culture of hUCS-MSCs
All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated. Umbilical cords (n=22) obtained from full-term deliveries were transferred to the laboratory in sterile Leibovit's 15 (L-15) media supplemented with penicillin (200 U/mL), streptomycin (200 g/mL) and amphotericin-B (5 g/mL). Ethical approval was obtained from the Institutional Ethical Review Board (approval no. 69-1780-2005). hUCS-MSCs were isolated, cultured and expanded as described in details elsewhere [4] . Following the first, third and sixth passages, cells were used for morphologic, proliferative and functional analyses.
Cryopreservation & Thawing Procedures
The confluent cells were treated with 0.05% trypsin-EDTA and then the viable/total cell ratio was determined by the trypan blue dye exclusion assay using an automated cell counting device (Vi-CELL, Automated Cell Viability Analyzer, Beckman Coulter, Fullerton, CA). 1x10 6 viable cells were resuspended in 1.5 mL of one of the following freezing solutions (FSs) and placed in 1.8 mL cryo vials (Thermo Fisher Scientific, Denmark). In this study, P-CPAs to reduce cell injury due to the intracellular ice formation, and IPCPAs to protect cell membrane, were examined using as single or in combination. We compared five different CPA reagents dissolved either in L-15 or Dulbecco's Modified Eagle's Medium/Nutrient Mixture Ham's F-12 media (DMEM/F-12) to prepare a FS. All FSs include either FBS or HSA, and at least one P-CPA or IP-CPA, which significantly raised the osmotic pressure to balance the intracellular osmolarity responsible for water uptake. Osmotic pressure of each FS was measured between 1710-2485 mOsm/kg after preparation (Osmomat, Gonotec, Germany). L-15 media was used as the diluent for the first four FS, whereas fifth FS were prepared in DMEM/F-12 media. FS-1: Sucrose-DMSO-FBS; FS-2: Trehalose-DMSO-Fetal bovine serum (FBS); FS-3: HES-DMSO-human serum albumin (HSA); FS-4: Ethylene glycol (EG)-sucrose-FBS; FS-5: 10% DMSO and 10% FBS. Experiment groups were summarized in Table 2 .
Triplicate samples from five cords for each FS group were taken into the freezing experiments. Each cryo vial contained approximately 1x10 6 viable cells. All groups were internally divided into four subgroups for testing two freezing rates (0.3°C/min and 1°C/min), conventional freezing and vitrification. After adding CPA(s), cryotubes were immediately placed in computer-controlled slow rate freezer (IceCube, SyLab, Austria). In computer-controlled MSSF protocol, all samples were cooled down to 0°C from room temperature at 2°C/min, kept there for 10 min for an equilibrium between sample and cooling chamber. An initial test run was carried out to determine the ice nucleation temperature for each solution. After that, latent heat of fusion was suppressed with appropriate temperature rate (°C/min) during freezing and cooling. Freezing program parameters were specifically designed for each FS. We compared two different cooling rates (down to -40°C at 1°C/min or 0.3°C/min then cooling to -80°C at 5°C/min). As the control of MSSF groups, hUCS-MSCs were also frozen by the empiric, conventional method using a freezing container (Mr. Frosty ® Nalgene, Rochester, NY), which is considered to freeze cells at a rate of 1°C/min. After adding the same CPA combination as in MSSF protocols, cryo vials were immediately placed into Mr. Frosty ® and were stored in an -80°C freezer overnight, and then immediately transferred to liquid nitrogen.
Alternatively, hUCS-MSCs were cryopreserved by the vitrification method using a two-step exposure to equilibration and vitrification solutions. The equilibration solution (ES) contained 20% EG while vitrification solution (VS) was composed of 40% EG, 18% Ficoll 70 and 0.3 M sucrose. Both ES and VS were based on Dulbecco's PBS (D-PBS) containing 20% FBS. 1x10 6 viable cells were first suspended in 50 mL ES for 5 min, and then mixed with 500 mL VS for 40 seconds. Suspended hUCS-MSCs were immediately transferred to 1.8 mL cryo vials (Thermo Fisher Scientific) and plunged directly into liquid nitrogen.
After 3-8 weeks of storage in liquid nitrogen, 15 cryo vials from each group were thawed rapidly by immersing the cryo vials in a water bath at 37°C and were suspended in D-PBS containing a serial dilution of sucrose (0.5, 0.25 and 0.00 M sucrose), and 20% FBS. After thawing, the survival rate was assessed by the automated trypan blue dye exclusion assay. The remaining cells were plated at a density of 5x10 4 cells/cm 2 in a 75cm 2 culture flask and subcultured over 8 weeks.
Flow Cytometry
Frozen/thawed and non-cryopreserved fresh hUCSMSCs were examined for the expression of a series of CD markers using a fluorescence-activated cell sorter (FACS Calibur, Becton Dickinson, CA, USA) equipped with Cell Quest ® software. At least 10,000 cells were analyzed per sample. Trypsinized hUCS-MSCs were resuspended in DMEM/F-12 supplemented with 10% FBS and washed with PBS (pH=7.2). Cells were incubated with primary antibodies for 1 hour at 37°C. Unbound antibodies were removed by washing with PBS. The following primary mouse monoclonal antibodies conjugated with either fluorescein isothiocyanate (FITC), phycoertythrin (PE) or allophycocyanin (APC) were used to detect CD expressions of CD29-FITC, CD34-APC, CD45-FITC, CD54-FITC (Becton Dickinson San Jose, Calif., USA), CD73-APC, CD90-APC, CD105-FITC, CD133-FITC, (eBioscience, Inc., San Diego, CA).
Immunocytochemistry
Fresh and cryopreserved hUCS-MSCs were plated and cultured on round glass coverslips placed in 24-well culture plates (Orange Scientific, Belgium). At appropriate intervals (P 1 -P 6 ), cells were fixed with 3.5% paraformaldehyde at 37°C for 30 minutes and rinsed with PBS. Mouse monoclonal antibodies to vimentin, pan-cytokeratin (cytokeratin types 4, 5, 6, 8, 10, 13, 18), -smooth muscle actin ( -SMA), CD105 (Becton Dickinson, San Jose, Calif., USA). FITCconjugated goat anti-mouse IgG (Jackson Immunoresearch Laboratories, Inc, West Groove, PA, USA) was used as a secondary antibody. 7-Aminoactinomycine D (7-AAD) (100 M for 20 minutes), and Hoechst 33258 (1 g/mL in 1:1 PBS/glycerol mounting medium) were used for nuclear labeling. Unless otherwise indicated, all antibodies were diluted 1:100 in PBS and incubated for 90 minutes at 37°C in a humidified chamber. All immunofluorescent labelings and dyes were examined using a Carl Zeiss LSM 510 confocal laser-scanning microscope equipped with 488-nm argon ion and 543-nm helium neon laser lines. Three-dimensional im- 
RESULTS
Determining the Ice Nucleation Temperature for Each FS
Samples were cooled down to nucleation temperature, which varied among each FS group (FS-1: -10.2°C; FS-2: -18°C; FS-3: -13°C; FS-4: -24.5°C; FS-5: -7.8°C). Heat release, known as the "latent heat of fusion" or crystallization (Fig 1A) during ice formation has been suppressed to avoid any heat evolution by controlling the nucleation temperature (Fig 1B) . In each FS group, thermal profile setting was precisely adjusted by cooling down to -40°C at a rate of 60°C/min starting at the nucleation temperature of the each group (Fig. 1) . FS-1 and FS-5 were cooled down by a 9-step Fig. (1). (A) A typical freezing time vs. temperature curve shows a prominent rise (shoulder) when the nucleation energy emerges called as "latent heat evolution". If the sample temperature further declines, this temperature rise will be compensated by the decline of the sample temperature. (B) Controlled-rate slow freezing protocol should aim to avoid the emergence of this heat by suppressing the shoulder with a sudden and deep drop of the set temperature (gray line) prior to nucleation. As a result, a sudden drop of sample temperature would not allow creating a shoulder (black line). Precisely aligned program settings to avoid the latent heat evolution for FS1 through FS-5 are given in tables.
program, while the others needed a 10-step program to cool down to -120°C.
Viability and Long-Term Proliferation Rates of Cryopreserved hUCS-MSCs
Cell viability of post-thaw hUCS-MSCs frozen with five different FSs was assessed to determine the efficiency of FSs and freezing protocols. It turned out that FS-1 composed of sucrose+DMSO+FBS provided highest cell viability compared to all other solutions ( Fig. 2A and Table 3) . In two samples, viable cell was found 92% of all frozen cells. FS-5 showed the second highest cell survival rates and the difference between those two groups were not found significant (p=0.13). FS-2 and FS-4 media provided slightly lower rates than the FS-1 and FS-5 groups. In all groups, 1°C/min freezing rate consistently gave higher survival rates compared to 0.3°C/min and conventional freezing groups. Interestingly, the viability of hUCS-MSCs after vitrification was 17.8±15%. All program settings and results are documented in Fig. (2A) and Table 3 .
The non-cryopreserved (prior to freezing) and post-thaw hUCS-MSCs that were frozen at rates 1°C/min, 0.3°C/min and conventionally frozen ones were then cultured until P 6 . The 1°C/min freezing rate provided higher proliferation rates compared to the 0.3°C/min and conventionally frozen cells (Fig 2B) . By the end of sixth passage, the number of unfrozen cells reached to around 6.5x10 9 , while 4.3x10 9 , 3.7x10 9 and 3.3x10 9 cells were cumulatively counted in 1°C/min, 0.3 °C/min and convention freezing groups, respectively.
Morphology of Cryopreserved hUCS-MSCs
A batch of fresh and frozen/thawed hUCS-MSCs from FS-1 and FS-5 groups was morphologically examined after culturing under the same conditions. Two distinct cell phenotypes were observed, particularly in early passages. Flat, wide cytoplasmic cells, previously named as type-1 cells [6] possessed myofibroblastic phenotype while slender, fibro- blastoid cells named as type-2 cells dispersed among type-1 cells (Fig. 3A) . As passages proceeded, the number of type-1 cells declined, while type-2 cells became dominant in monolayer cultures (Fig. 3B) . Freeze and thaw processes in all groups did not show any change in cell morphology and type-1/type-2 cell ratio ( Fig. 3C and D) .
To confirm the preliminary observations in fresh cell cultures, hUCS-MSCs were cultured in poly-L-lysine coated glass coverslips, fixed and then stained with antibodies against vimentin and cytokeratin, which are mesenchymal and ecto-/endodermal markers, respectively. Type-1 and type-2 cells expressed vimentin ( Fig. 4A and B) , whereas cytokeratin was restricted to type-1 cells (Fig. 4D and E) . The contractile protein -smooth muscle actin ( -SMA) was expressed mainly in type-1 cells, which depicted their contractile properties ( Fig. 4G and H) . CD105 (endoglin), a recognized marker for MSCs as a membrane glycoprotein located on cell surfaces was also expressed in almost all cells before and after freezing ( Fig. 4J and K) . No significant difference was noted before and after the cryopreservation in terms of protein localization and distribution. The above protein localization and distribution was also checked in later passages after a freeze/thaw cycle that no significant differences were observed (P 6 is shown in Fig. 4C, F, I and L) .
Since the freezing conditions and some CPAs used in present study have the potential to trigger some chromosome abnormalities and cell division errors, the mitotic figures starting from prophase through telophase were also visualized using DNA-specific dyes (Hoechst 33258 and 7-AAD) by labeling the condensed chromosomes. The percentage of M-phase cells (cells in mitosis vs. interphase cells) and the orientation of mitotic chromosomes in thawed cells were found not different from freshly analyzed cells (Fig. 5) . Metaphase, anaphase and telophase figures, in particular displayed clear chromosome separation with no aberrant 
Expression of Surface Antigens by Flow Cytometry
The cell surface antigen profiles of non-cryopreserved and cryopreserved hUCS-MSCs at P 1-3 were analyzed. Thawed hUCS-MSC showed strong immunoreactivity for CD29, CD 73, CD90, and CD105; weak positivity for CD54 and no positivity for CD34, CD45, and CD133 ( Table 4) . These expression patterns were similar to non-cryopreserved hUCS-MSC except a slight decline (28%) in CD54, and a rise in CD90 (14%) was noted after freezing.
DISCUSSION
Cryopreservation media, CPAs added, the final sample freezing temperature, cooling and warming rate should all be considered before liquid nitrogen plunge, in developing a protocol for successful cryopreservation of cells. The results of our experimental design showed that the most important factor influencing the viability of cells is the freezing rate after nucleation. Cryobiological studies have shown that different types of cells, even when frozen in the same solution, require different optimum cooling rates, and cooling rate can exert significant effects on the survival of cells after freezing [27] . In the present study, we demonstrate that appropriate cooling rate for hUCS-MSCs is 1°C/min, which seemed superior to 0.3°C/min. We successfully cryopreserved hUCSMSCs, and confirmed that the cells preserve their typical morphology, cell markers as compared to non-cryopreserved controls. Lack of any abnormality in mitotic figures was confirmed by the other laboratories that hUCS-MSC do not display any sign of chromosomal missegregation as previously detected by karyotype analyses [6, 28] even after passage 13 [28] , which corresponds to around 50 population doublings. Although, we did not perform karyotyping to detect aneuploidy if any, high power images of consecutive mitotic chromosome alignments indicated neither any displaced chromosomes nor any centrosomal instability. There are con- AF flicting data in the literature reporting that aneuploidies and structural chromosomal changes could result due to the cultivation period [29] . Large chromosomal structural changes in particular were generally found in long-term cultures [30, 31] . Nevertheless, genetic stability still stands as one of the main issues that may arise during extensive processing of MSCs for therapeutic purposes.
Slow freezing is a method used to balance the damage caused by various factors, including ice crystal formation, fracture, toxic and osmotic damage, by decreasing temperature slowly with low concentration of CPA [32] . Slow freezing has been principally used for cryopreservation of various cells, including human embryos. Many authors used a similar slow freezing rate, which is derived from embryo freezing protocols [33] . Fong et al. [24] have used a simpler controlled-rate freezer to cryopreserve hUCS-MSCs without any particular effort to suppress the latent hear evolution and reported a 85-90% cell viability after thawing. Recently, de Lima Prata et al. reported a freezing solution of 10% human serum, 10% DMSO and 20% HES could provide around 73% viable cells using a commercial automated multi-step cryofreezer in plastic bags [34] . These authors also tested the toxicity of DMSO in post-thaw samples and concluded that hUCS-MSCs are relatively resistant to DMSO toxicity. Many authors including our group who used a conventional freezing method, where an empirically 1°C/min cooling and freezing rate is applied, gave much lower viability rates [6, 8, 35] . Motta et al. reported a higher preservation rate of CD34 + cells from umbilical cord blood samples using a MSSF program [36] . They demonstrated that besides DMSO+sucrose or DMSO+trehalose, two antioxidant agents -catalase and ascorbic acid -improved the cryopreservation outcome. Rodrigues et al., on the other hand, lowered the concentration of DMSO, by which some adverse affects have been described after use in humans, by replacing with sucrose or trehalose, and reported similar cryopreservation outcomes using a MSSF program [37] .
P-CPA and the IP-CPAs have different effects on the viability of cells. The most widely used P-CPA is DMSO, which is a hygroscopic polar compound developed originally as a solvent for chemicals [38] , while trehalose is a membrane stabilizing sugar that has the ability to form stable glasses during cooling [39] . The inclusion of sucrose as an additive in freezing media to preserve human fetal liver cells enabled a reduction in the concentration of DMSO, replacing serum and increasing the efficiency of cryopreservation [40] . Hematopoietic stem cells, on the other hand, could be successfully cryopreserved with 1/4 of the standard DMSO concentration with the addition of disaccharides [37] . Human bone marrow cells with 10% DMSO and 10% autologous plasma or DMSO-HES-HSA (5% dimethylsulfoxide, 6% hydroxyethyl starch, 4% human serum albumin) were frozen by a programmed freezer or in a -80°C refrigerator, then preserved in liquid nitrogen for long time. Even preserving time had been extended to 21-25 years, cell morphology, the recovery rate and the activity of various kinds of cells were found fairly good [41] . Some groups investigated the freezing rate for hUCS-MSCs in the presence or absence of CPA, including DMSO and glycerol. Our study shows, for the first time, that using the combination of DMSO and sucrose gives a relatively high cell survival for hUCS-MSCs. In addition, our protocol also allowed us to proliferate and expand hUCS-MSC population immediately after thawing. Upon thawing after MSSF, hUCS-MSCs recovered with acceptable viability (mean=87±5%), even after 2-week storage. Moreover, the cryopreserved hUCS-MSCs showed a prolonged growth capacity without any changes in their morphology or immunophenotypic properties.
We have performed a cell surface marker assay by flow cytometry before and after freezing. Although, there is no clear consensus regarding the hUCS-MSC-specific markers, many core markers and HLA-DR levels in MSCs remained unchanged after cryopreservation. It was important to notice that after freeze/thaw cycles; cells maintained the core markers while lacking HLA-DR, which is a sign of hypoimmunogenicity of hUCS-MSCs as demonstrated by others [25, 28] . Among two of nine markers detected CD54 and CD90 relatively changed after a freeze/thaw cycle; the number of CD54 + cells declined (28%), while CD90 + cells increased (14%). Both surface proteins are related to cell-cell contact. CD54, known as ICAM-1 binds to the integrins at the extracellular site. Besides its major localization in monocytes, vascular endothelial cells and lymphocytes, it is also considered as a MSC marker. CD90, originally a thymocyte marker, is also considered as a "surrogate" marker of hematopoietic stem cells and MSCs. Although, its function has not been fully elucidated, it has speculated roles in cell-cell and cell-matrix interactions, apoptosis, inflammation and fibrosis. In a functional point of view, the decline of CD54 might reflect the partial loss of MSC adhesion, while a slight increase in CD90 may be due to enhanced adhesion and other functions of cells. Nevertheless, our findings do not rule out the possibility of being an experimental error, since out data set is not big enough to accept the flow cytometry results as a universal outcome.
Most freezing protocols use a FS supplemented with FBS. Serum supplementation is practical because it provides the cells with vital nutrients, attachment, and growth factors during expansion and differentiation of cells. This is also true for providing a higher cell survival rate after a freeze/thaw cycle. However, in terms of clinical use of MSCs, regulatory guidelines aim to minimize the use of FBS, because it carries the risk of transmitting viral and prion diseases and proteins that may initiate xenogeneic immune responses. Although many clinical data have been accomplished with MSCs having been expanded in FBS supplemented media without the appearance of major side effects; in some cases, however, immunological reactions and anti-FBS antibodies have been observed and considered as having possibly affected the therapeutic outcome [42, 43] . In recent years, human platelet lysate (PL) is known to be a safely used alternative to FBS during the expansion and differentiation of human MSCs [44] . hUCS-MSCs were cultured using human PL in a few study [45] [46] [47] [48] where immunophenotypic profile and in vitro differentiation capacities of hUCS-MSCs were examined. Briefly, PL-treated hUCS-MSCs were differentiated poorly into chondrogenic, osteogenic and adipogenic lineages compared to bone marrow MSCs [45, 47] . However, all four studies reported that cell surface profiles were indifferent than untreated or FBStreated samples. No study has been published so far, testing the viability and competence of PL-treated human UCSMSCs after a freeze/thaw cycle, so it would be wise to test the effect of PL in frozen/thawed UCS-MSCs. The concentration of PL would also be an issue, since it is generally used in lower concentrations than FBS.
During freezing, cells rarely come into direct contact with ice crystals rather they become concentrated into the unfrozen fraction where they are exposed to a number of physical stresses [20] . It is the cellular response to these stresses, which determines cell survival. Cells are exposed to all these stresses such as membrane lipid phase changes, depolymerization of the cytoskeleton, osmotic shrinkage, mechanical damage and denaturation of the proteins, all of which are changing during solidification. However, it is the osmotic response of cells that is the primary determinant of viability. The hypertonic conditions of the cells encounter lead to an osmotic loss of water, the extent of which is de-pendent on the rate of cooling. At "slow" rates of cooling, cells may remain essentially in equilibrium with the external solution, reaching low temperatures osmotically shrunken with the intracellular compartment sufficiently viscous so that the cells eventually vitrified. As the rate of cooling increases, there is less time left for water to be emitted from the cell, which becomes increasingly supercooled and eventually intracellular ice formation occurs -this is inevitable lethal. Therefore, osmotic pressure of the cooling environment becomes extremely important that keeps the cells within the normoosmotic conditions as much as possible that will prevent cells to shrink beyond the critical volume (eutectic point). We have carefully adjusted and then measured the osmolarity of each FS we tested. In our preliminary experiments, we have encountered many viability problems because of the improper osmolarity levels (mostly low osmolarity) arose particularly from the vehicle medium composition. The rationale of choosing a vehicle medium like L-15 based on the fact that L-15 medium is a complex NaHCO 3 -free formulation having 285 mOsm/kg osmolarity. A variety of factors are known to influence cell survival during cryopreservation, but the role of the vehicle solution for the CPAs is often overlooked. It is generally assumed that conventional culture media used to nurture cells at physiological temperatures will also provide a suitable medium for exposure at low temperatures. However, it is now well established in tissue and organ preservation that the ionic and hydraulic balance in cells during hypothermia can be better controlled by using solutions designed to physically restrict temperature-induced imbalances [49] . Optimum control of the cells environment during cryopreservation demands that is considered the chemical composition of the buffer medium used as a vehicle for the CPAs as well as the temperature to, which the cells are exposed. Although, conventional culture media are commonly used for this purpose, it should not be assumed that a tissue culture medium is an ideal or optimum vehicle solution for exposing cells to low temperatures. L-15 was particularly designed for use in carbon dioxide-free cell culture systems and we have used it without any significant pH and osmolarity shift for years in our laboratory. As DMEM/F-12 is a widely used culture media and a freezing vehicle, we wanted to test its efficiency in FS-5. As the results showed, FS-5 provided the second highest survival rates with no addition of IP-CPA. The success rate of DMEM/F-12 containing FS may actually come from the success rate of MSSF and relatively high (2011 mOsm/kg) osmotic pressure due to the lack of any IP-CPA.
Preservation by cooling is achieved by striking a balance between the beneficial and harmful effects of reducing temperature [19] . The most beneficial effect of cooling is the slowing of chemical reactions and, therefore, the decreased demand for oxygen and other substrates and the conservation of chemical energy. Rapid cooling may be harmful due to thermal shock. It is a common practice in tissue banking to use tissue culture media as the base solution for preservation media. However, there are good reasons why tissue culture media, which are designed to maintain cellular function at normal physiological temperatures, are inappropriate for optimum preservation at reduced temperatures. Maintaining the ionic and hydraulic balance within tissues during hypothermia can be better controlled in media designed to physically restrict these temperature-induced imbalances. This principle is embodied in the design of organ preservation solutions used for short-term hypothermic storage of kidneys, livers, and hearts without freezing [50] and can be applied equally to the choice of vehicle solution for adding and removing CPAs in a cryopreservation protocol.
Controlling nucleation and the temperature compensation provided during controlled rate preservation for release of the latent heat of fusion results in improved post-freeze cell viability [19] . This is a major reason to use controlled rate freezing equipment rather than simply to place samples in cold environments as we have tested our samples by conventional freezing conditions as well. Optimal slow cooling conditions resulting in retained cell viability are defined by the cooling rate that permits some cell shrinkage (dehydration) without the formation of significant amounts of intracellular ice. Tolerances for cell shrinkage and intracellular ice formation vary between cell and tissue types.
In conclusion, we developed a relatively optimum cryopreservation solution and a controlled-rate program for freezing of hUCS-MSCs. We, therefore assume that these cells could be saved for years using this reliable and effective cryopreservation method. The first hUCS-MSCs bank complying with GMP has been established in China in 2006 [51] . During the period between May 2006 and December 2008, a total of 5400 umbilical cords were collected and 4428 (82%) were finally stored. The P 7 cells were used to manufacture final cell products for animal studies and clinical trials in that as many as approximately 1010 cells without signs of senescence or chromosomal abnormalities could be harvested at P 7 [51] . Undoubtedly, many other cord stroma banks are on the waiting line to be established. As Secco et al. highlights the importance of this issue [52] human UCS-MSCs banking will open up interesting new possibilities for cell therapy and regenerative medicine. 
